product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
EEFSEC Antibody [Alexa Fluor Plus 680]
catalog :
NBP2-97519AFP680
quantity :
0.1 ml
price :
369 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
immunohistochemistry - paraffin section
more info or order :
product information
brand :
Novus
master code :
NBP2-97519AFP680
SKU :
NBP2-97519AFP680
product name :
EEFSEC Antibody [Alexa Fluor Plus 680]
sizes available :
0.1 ml
description :
The EEFSEC Antibody [Alexa Fluor Plus 680] from NBP2-97519AFP680 is a 6.7e-05 antibody to . This antibody reacts with human.
target :
EEFSEC
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Polyclonal
conjugate :
Alexa Fluor Plus 680
dilution :
Immunohistochemistry-Paraffin
host :
Rabbit
immunogen :
Produced in rabbits immunized with E. coli-derived Human EEFSEC fragment.
isotype :
IgG
purity :
Antigen and protein A Affinity-purified
species :
Human
gene symbol :
EEFSEC
applications :
Immunohistochemistry-Paraffin
USD :
369 USD
alt names :
eukaryotic elongation factor, selenocysteine-tRNA-specific
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- DLX3 Antibody [Alexa Fluor Plus 647] | NBP2-97552AFP647
- EEFSEC Antibody [Alexa Fluor Plus 647] | NBP2-97519AFP647
- DLX3 Antibody [Alexa Fluor Plus 594] | NBP2-97552AFP594
- DLX3 Antibody [Alexa Fluor Plus 488] | NBP2-97552AFP488
- P-Selectin/CD62P Antibody (001) [Alexa Fluor Plus 680] | NBP2-90156AFP680
questions and comments
